acetylcysteine has been researched along with Chronic Kidney Disease-Mineral and Bone Disorder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, MR; Avin, K; Chen, N; McNerney, E; Moe, S; Nyman, J; Wallace, J | 1 |
1 other study(ies) available for acetylcysteine and Chronic Kidney Disease-Mineral and Bone Disorder
| Article | Year |
|---|---|
N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder.
Topics: Acetylcysteine; Animals; Antioxidants; Caseins; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Models, Animal; Disease Progression; Glycation End Products, Advanced; Humans; Kidney; Lipid Peroxidation; Male; Mutation; Nuclear Proteins; Oxidative Stress; Parathyroid Hormone; Rats; Tibia; X-Ray Microtomography | 2020 |